Literature DB >> 4061408

Cat-scratch disease. An overview based on a study of 1,200 patients.

H A Carithers.   

Abstract

This study by one individual of 1,200 patients with cat-scratch disease provides a heretofore unavailable realistic evaluation of a common infectious disease. All patients had lymphadenopathy, a prerequisite for diagnosis. Suppuration occurred in 11.8% of patients. Cat contact was established for 99.1%, and the cat was immature in the vast majority. An inoculation site, the most neglected feature in the study of the patients, was detected in 92.6%. The results of a skin test, considered as specific as the standard tuberculin test and to be safe but not standardized, was positive in 99%. The 12 patients with negative skin tests probably were tested too early in the course of the disease to have developed reactivity. Skin tests of 578 family members of patients, who served as controls, gave positive results in 18.5%. Of 60 patients with unusual manifestations, 48 had the oculoglandular syndrome of Parinaud. Other manifestations included erythema nodosum, encephalopathy, osteolytic lesions, thrombocytopenic purpura, and erythema marginatum. Most patients in this series had received antibiotics of many types during the course of the disease. None appeared beneficial. The disease is benign in character in a majority of patients. Surgical removal of involved lymph nodes or biopsy of lymph nodes or inoculation sites is not necessary for diagnosis or management. A survey of hospitals in the United States discharging more than 750 pediatric patients annually indicates that cat-scratch disease is a problem in all sections of the country.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4061408     DOI: 10.1001/archpedi.1985.02140130062031

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  101 in total

Review 1.  Natural history of Bartonella infections (an exception to Koch's postulate).

Authors:  V Jacomo; P J Kelly; Didier Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

2.  Diagnostic aspects of cervical lymphadenopathy in children in the developing world: a study of 1,877 surgical specimens.

Authors:  S W Moore; J W Schneider; H S Schaaf
Journal:  Pediatr Surg Int       Date:  2003-04-17       Impact factor: 1.827

Review 3.  Current knowledge of Bartonella species.

Authors:  M Maurin; R Birtles; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

4.  Prevalence of Bartonella species in domestic cats in The Netherlands.

Authors:  A M Bergmans; C M de Jong; G van Amerongen; C S Schot; L M Schouls
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 5.  Recommendations for treatment of human infections caused by Bartonella species.

Authors:  J M Rolain; P Brouqui; J E Koehler; C Maguina; M J Dolan; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

6.  [Solitary nontuberculous mycobacterial infection of a cervical lymph node caused by Bartonella henselae (cat scratch disease)].

Authors:  M Erbe; R Lindenfelser
Journal:  Mund Kiefer Gesichtschir       Date:  2004-09-09

7.  Encephalitis in cat scratch disease with persistent dementia.

Authors:  A Revol; A Vighetto; A Jouvet; G Aimard; M Trillet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

8.  Treatment of adult systemic cat scratch disease with gentamicin sulfate.

Authors:  D E Lewis; M R Wallace
Journal:  West J Med       Date:  1991-03

9.  Differentiation of Bartonella-like isolates at the species level by PCR-restriction fragment length polymorphism in the citrate synthase gene.

Authors:  A F Norman; R Regnery; P Jameson; C Greene; D C Krause
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

10.  Experimental transmission of Bartonella henselae by the cat flea.

Authors:  B B Chomel; R W Kasten; K Floyd-Hawkins; B Chi; K Yamamoto; J Roberts-Wilson; A N Gurfield; R C Abbott; N C Pedersen; J E Koehler
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.